Table 1 List of patient characteristics for ovarian tissue fragments that were xenografted into NSG mice.
From: Engineered endothelium provides angiogenic and paracrine stimulus to grafted human ovarian tissue
Patient # | Patients’ age at cryopreservation | Fresh-F/Thawed- T | Main reason for cryopreservation | Chemo Rx | # of pieces used | # of mice used |
|---|---|---|---|---|---|---|
1 | 19 | F | Hodgkin’s | ABVD | 6 | 1 |
Lymphoma | ||||||
2 | 32 | F | Hodgkin’s | Yes | 6 | 3 |
Lymphoma | ||||||
3 | Â | T | Â | No | 6 | 2 |
4 | Â | T | Â | No | 4 | 2 |
5 | 19 | T | Ewing’s sarcoma | No | 12 | 6 |
6 | 17 | T | Hodgkin’s stage IV | No | 2 | 1 |
7 | 5 | T | Beta Thalassemia | No | 6 | 3 |
8 | 6 | T | Thalassemia Major | Â | 2 | 1 |
9 | 17 | T | Cancer | No | 4 | 2 |
10 | 26 | T | Hodgkin’s | ABVD, | 8 | 4 |
Lymphoma | Lupron depot | |||||
11 | 18 | T | Lymphoblastic lymphoma | Doxorubicin, | 4 | 2 |
Ara C, vincristine, PEG-asparaginase, MTX | ||||||
12 | 5 | T | Beta thalassemia | No | 4 | 2 |
13 | 18 | T | Â | Chemo | 8 | 4 |
14 | 18 | T | Non-Hodgkin Lymphoma | Â | 4 | 2 |
